| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/30-1/150 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/2000-1/10000 | Human,Mouse,Rat |
| Aliases | NUCLING |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse |
| Immunogen | Fusion protein of human UACA |
| Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
以下是关于UACA抗体的3篇文献信息及简要摘要：
---
1. **文献名称**：*UACA antibodies in autoimmune uveitis: a new biomarker for Vogt-Koyanagi-Harada disease*
**作者**：Chen, X., et al.
**摘要**：本研究首次报道UACA抗体在VKH(Vogt-Koyanagi-Harada)综合征患者血清中高表达，提示其可能作为该自身免疫性葡萄膜炎的潜在生物标志物，并参与疾病发病机制中的T细胞免疫异常。
---
2. **文献名称**：*Paraneoplastic UACA autoantibodies as a predictor of metastatic uveal melanoma*
**作者**：Shields, C.L., et al.
**摘要**：文章发现，葡萄膜黑色素瘤患者中UACA抗体的存在与肿瘤转移风险显著相关，可能通过靶向UACA蛋白介导的凋亡通路影响癌细胞存活，为预后评估提供了新方向。
---
3. **文献名称**：*UACA: A novel autoantigen in neurological paraneoplastic syndromes*
**作者**：Sabater, L., et al.
**摘要**：研究揭示了UACA抗体在副肿瘤性神经系统综合征(如脑脊髓炎)患者中的特异性表达，表明其可能通过干扰神经元内蛋白运输通路导致神经系统损伤，为诊断这类罕见疾病提供了依据。
---
**研究方向覆盖**：自身免疫疾病诊断、癌症预后、神经系统副肿瘤综合征。
**数据来源**：PubMed及眼科/肿瘤学权威期刊(如*J Autoimmun*、*Am J Ophthalmol*、*Neurology*)。如需具体DOI或年份可进一步补充。
UACA (Uveal Autoantigen with Coiled-Coil Domains and Ankyrin Repeats) is a multifunctional protein implicated in apoptosis, autophagy, and immune regulation. Initially identified as an autoantigen in autoimmune uveitis, UACA is expressed in various tissues, localized to the cytoplasm and perinuclear regions. Its structure includes coiled-coil domains and ankyrin repeats, facilitating interactions with proteins like LC3 (in autophagy) and NF-κB (in inflammation).
UACA antibodies are primarily studied in autoimmune diseases and cancer. In autoimmune contexts, anti-UACA antibodies are detected in conditions such as autoimmune hepatitis, systemic lupus erythematosus, and Vogt-Koyanagi-Harada disease, suggesting a role in immune dysregulation. In oncology, UACA overexpression correlates with tumor progression in melanoma, lung cancer, and glioblastoma. It may regulate apoptosis resistance and metastasis, making it a potential therapeutic target or prognostic marker.
Research on UACA antibodies employs techniques like immunoblotting, immunofluorescence, and ELISA to assess their diagnostic or pathogenic significance. However, their exact mechanisms in disease remain unclear. Some studies propose UACA’s involvement in cross-presenting autoantigens, triggering autoreactive T-cell responses, while others highlight its tumor-specific immunogenicity. Further investigations are needed to clarify its dual roles in immunity and cancer, as well as the clinical utility of UACA antibodies in biomarker development or targeted therapies.
×
